State regulators are spending unnecessary time and money trying to police a private testing model that fails to protect consumers.
From Maryland’s newly launched CSQ CLEAR audit pilot to New York’s shutdown of Lexachrom Analytical Laboratory, Michigan’s historic license revocations of Viridis Laboratories, and New Jersey putting out RFPs to audit its testing ecosystem, regulators remain stuck in an endless game of whack-a-mole. More regulations cannot fix a system where private labs rely on growers to stay in business. As long as testing facilities compete for commercial clients, lab shopping, moisture manipulation, and THC inflation will remain standard operating procedure.
A History of Tampering: The High-THC Payday
The industry has called out lab shopping for years. Cultivators steer their business toward testing facilities willing to report higher THC percentages, driven by consumer hyper-fixation on potency. Adding an extra 5% or 10% to a Certificate of Analysis (COA) drastically raises wholesale crop value. If one lab refuses to play ball, the grower simply takes their testing batch down the street.
To hit those inflated numbers, labs rely on a few standard tricks:
- Baking Out Moisture: Over-drying flower samples before testing reduces water mass, automatically driving up the THC ratio on paper.
- Manipulating Calibration Baselines: Technicians alter standard reference values on testing equipment so samples appear significantly stronger by comparison.
- Fudging Sample Weights: Labs extract 0.3 grams of flower but log 0.2 grams in the software, forcing the system to divide the total THC mass by a smaller weight to inflate the final percentage.
The Pay-to-Play Problem: Why States Should Take Over Testing
Regulators have issued fines, suspended licenses, and pulled operating permits for years, yet bad behavior persists across state lines. Multi-lab audits, cross-testing pilots, and state contract RFPs show just how much public money states are burning to babysit private facilities—building complex forensic networks and hiring outside consultants just to catch bad data after the fact.
It makes no sense to spend tax dollars policing a system when changing the model fixes it instantly.
Bringing compliance testing directly under state authority removes the financial incentive to cheat. Under a state-operated model, cultivators pay standard state fees to fulfill mandatory testing requirements. Private deals, profit margins, and lab competition disappear overnight. Instead of throwing tax dollars at endless oversight, states streamline product safety and turn required compliance testing into a self-sustaining, revenue-generating function for the state.
Playing Catch-Up Across the Country
Enforcement sweeps and regulatory expenditures in individual state markets prove that auditing private labs is just playing catch-up:
- New Jersey: The Cannabis Regulatory Commission recently issued a competitive RFP for a Biannual Cannabis Testing Program Assessment, allocating government resources to analyze and evaluate the reliability of its commercial testing framework.
- Michigan: The Cannabis Regulatory Agency revoked licenses and permanently banned the owners of Viridis Laboratories following long-running allegations of potency inflation and unreliable safety tests that previously triggered a $229 million product recall. To regain control, Michigan spent state resources to build its own state reference lab.
- New York: Regulators forced the closure of Lexachrom Analytical Laboratory after an audit uncovered systemic data integrity violations, triggering market-wide product recalls for untested inventory.
- Maryland: Regulators launched the CSQ CLEAR cross-testing pilot to benchmark retail flower against state reference labs in an effort to identify statistical outliers.
- Multistate Revocations: California, Arizona, and Massachusetts have repeatedly suspended or revoked testing permits over falsified logs, moisture manipulation, and sample tampering like dusting flower with THC distillate.
Looking Ahead
Programs like Maryland’s CSQ CLEAR pilot and New Jersey’s testing assessments will continue collecting data, but audits only diagnose the symptom. Until states stop spending money on reactionary policing and move compliance testing directly under state authority, the private lab market will continue to privilege high THC numbers over scientific truth.
The post Cannabis Testing Is Broken Across State Lines. State-Run Testing Is the Real Fix appeared first on Cannabis Industry Journal.
